← All deals

Khona Scientific Holdings, Inc.

Other TechnologySynthetic BiologyBiotechnologyBiosynthesis
📍 Lone Tree, Colorado, United States
StreetZero Signal 65
Be the first to signal interest

About Khona Scientific Holdings, Inc.

Khona Scientific Inc. (KSI) is a synthetic biology company with a patented biosynthetic platform technology (BiDS™) that simplifies production of complex compounds difficult or costly to procure through conventional extraction or traditional biosynthesis methods. The BiDS™ technology provides an inexpensive alternative for naturally-derived key ingredients used in Cosmetics, Nutraceuticals, Pharmaceuticals and other verticals. Headquartered in Lone Tree, Colorado, with laboratory operations in Boulder, Colorado, the company integrates enzymatic pathways into cellular assembly lines for commercial applications. It has signed a letter of intent with Benuvia Operations to advance biosynthetic development of controlled-substance APIs.

LATEST FUNDINGPrivate Placement
$3.2M
Announced 2026-10-06
🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Khona Scientific Holdings, Inc..

Free plan includes 3 full deal profiles every month.

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

  • Completed $3.183M private placement with undisclosed investors.
  • Patented BiDS™ biosynthetic platform enables low-cost production of complex natural compounds.
  • Headquartered in Lone Tree, CO with lab operations in Boulder, CO.
  • Signed LOI with Benuvia to develop biosynthetic controlled-substance APIs.
  • Operates in cosmetics, nutraceuticals, pharmaceuticals and specialty natural compounds verticals.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account